Results
11
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
11 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
EVER | RON 1.41 | -2.4% | 13.8% | RON 1.3b | n/a | PE4.4x | n/a | 6.4% | Diversified Financials | ||
INFINITY | RON 2.42 | -0.8% | 35.2% | RON 1.1b | RON 3.08 | PE4.6x | n/a | 0% | Diversified Financials | ||
PRBU | RON 1,270.00 | 2.4% | 2.4% | RON 736.5m | n/a | PE24.8x | n/a | 4.1% | Real Estate Management and Development | ||
CMVX | RON 80.00 | 0% | n/a | RON 909.2m | n/a | PE7.2x | n/a | 13.4% | Transportation | ||
SOCP | RON 1.69 | 0.3% | -22.7% | RON 1.1b | n/a | PE8.8x | n/a | 5.2% | Transportation | ||
SCD | RON 4.52 | 0% | 55.9% | RON 3.2b | n/a | PE11.6x | n/a | 0% | Pharmaceuticals & Biotech | ||
ARS | RON 8.80 | 4.8% | -6.4% | RON 1.3b | n/a | PE14.8x | n/a | 2.4% | Capital Goods | ||
BIO | RON 0.72 | 2.0% | -12.9% | RON 699.6m | n/a | PE8.8x | n/a | 4.3% | Pharmaceuticals & Biotech | ||
TEL | RON 46.15 | -2.9% | 47.9% | RON 3.4b | RON 35.90 | PE8x | S-13.1% | 0.6% | Utilities | ||
EL | RON 15.26 | 3.1% | 32.7% | RON 5.2b | RON 15.00 | PE8.9x | E1.6% | 0.8% | Utilities | ||
SFG | RON 41.00 | 1.0% | 51.3% | RON 1.6b | RON 39.18 | PE14.6x | E11.3% | 5.1% | Consumer Services |